Business Description

Chemed Corp, founded in 1968 and headquartered in Cincinnati, Ohio, United States, operates through its two primary segments: VITAS Healthcare, which provides hospice and palliative care services, and Roto-Rooter, known for emergency plumbing services. Led by CEO John Z. Block since 2015, the company has achieved notable market positions with approximately 20% of the U.S. hospice care market and an estimated 40% share in plumbing repairs nationally. It generates revenue from a diversified customer base through efficient, scale-driven operations. Future investments in technology and network expansion are set to drive its continued growth.

Financial Statements

In thousands, USD
FY 2025FY 2024FY 2023FY 2022
Total Revenues2,529,9802,431,2902,264,4202,134,960
Cost of Sales1,706,7901,576,9401,465,6001,369,880
Gross Profit823,184854,348798,815765,086
Selling, General & Administrative Expenses417,188424,360395,120358,727
Depreciation & Amortization Expenses64,84163,04960,86559,172
Other Operating Expenses2,9094462,2613,691
Operating Profit338,246366,493340,569343,496
Interest Expense(1,750)(1,780)(3,108)(4,584)
Non-Operating Income19,28234,75212,906(9,233)
Total Non-Operating Income17,53232,9729,798(13,817)
Income Before Provision for Income Taxes355,778399,465350,367329,679
Provision for Income Taxes90,54097,46677,85880,055
Consolidated Net Income265,238301,999272,509249,624
Net Income Attributable to Common Shareholders265,238301,999272,509249,624
Basic EPS18.4220.1018.1116.72
Diluted EPS18.3419.8917.9316.53
Basic Weighted Average Shares Outstanding14,39815,02415,05014,929
Diluted Weighted Average Shares Outstanding14,46015,18615,20015,099
Shares Outstanding13,71014,55615,03514,875
FY 2025FY 2024FY 2023FY 2022
Cash and Cash Equivalents74,515178,350263,95874,126
Total Cash and Cash Equivalents74,515178,350263,95874,126
Accounts Receivable182,575171,163181,511139,408
Total Trade Receivables182,575171,163181,511139,408
Inventories7,5438,19312,00410,272
Other Current Assets37,98337,04243,37048,806
Total Current Assets302,616394,748500,843272,612
Net Property, Plant & Equipment336,813328,160330,227335,376
Net Intangible Assets82,76492,20690,26499,726
Goodwill666,999666,744585,017581,295
Long-Term Investments140,347130,960106,12693,196
Other Long-Term Assets8,65055,75755,61859,807
Total Assets1,538,1901,668,5801,668,1001,442,010
Accounts Payable64,45944,14664,03441,884
Accrued Expenses122,887156,369153,807150,321
Current Portion of Long-Term Debt5,000
Current Portion of Leases40,89242,30638,63538,996
Other Current Liabilities58,89242,87455,57461,004
Total Current Liabilities287,130285,695312,050297,205
Long-Term Debt92,500
Leases102,86798,538100,776110,513
Other Long-Term Liabilities168,787165,349147,393143,079
Total Long-Term Liabilities271,654263,887248,169346,092
Total Liabilities558,784549,582560,219643,297
Common Stock37,59537,42237,18436,796
Treasury Stock(3,608,120)(3,126,660)(2,719,590)(2,588,150)
Additional Paid-in Capital1,592,2001,484,1801,341,2701,149,900
Accumulated Other Comprehensive Income2,3552,2232,0822,247
Retained Earnings2,955,3802,721,8302,446,9302,197,920
Total Common Shareholders' Equity979,4051,118,9901,107,880798,715
Total Shareholders' Equity979,4051,118,9901,107,880798,715
Total Liabilities and Shareholders' Equity1,538,1901,668,5801,668,1001,442,010
FY 2025FY 2024FY 2023FY 2022
Net Income265,238301,999272,509249,624
Depreciation & Amortization64,84163,04960,86559,172
Share-Based Compensation Expense38,68052,10940,79333,612
Other Adjustments(4,198)(9,567)(5,397)994
Changes in Trade Receivables(11,596)10,678(41,488)(2,414)
Changes in Inventories6503,831(1,732)(162)
Changes in Accounts Payable(5,194)(9,279)(9,348)15,343
Changes in Income Taxes Payable(6,217)2,18211,748(996)
Changes in Other Operating Activities46,0682,4952,349(45,287)
Cash from Operating Activities388,272417,497330,299309,886
Capital Expenditure(62,795)(49,531)(56,854)(57,325)
Proceeds from Sale of Property, Plant & Equipment4,5683,3156402,330
Payments for Business Acquisitions(225)(97,400)(3,994)(3,529)
Other Investing Activities(888)(295)(434)(878)
Cash from Investing Activities(59,340)(143,911)(60,642)(59,402)
Issuance of Short-Term Debt121,800
Repayments of Short-Term Debt(306,800)
Net Issuance / (Repayments) of Short-Term Debt(185,000)
Issuance of Long-Term Debt100,000
Repayments of Long-Term Debt(97,500)(2,500)
Net Issuance / (Repayments) of Long-Term Debt(97,500)97,500
Issuance of Common Shares27,15256,517102,19244,968
Repurchases of Common Shares(440,319)(370,846)(77,254)(130,126)
Net Issuance / (Repurchases) of Common Shares(413,167)(314,329)24,938(85,158)
Common Share Dividends Paid(31,695)(27,092)(23,502)(22,017)
Other Financing Activities12,095(17,773)16,239(14,578)
Cash from Financing Activities(432,767)(359,194)(79,825)(209,253)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash(103,835)(85,608)189,83241,231

Key Metrics & Ratios

MetricValue
Market Cap$5.87B
P/E23.33x
P/S2.32x
EV/EBITDA14.72x
Return on Equity25.3%
Return on Invested Capital18.7%
Current Ratio1.05x
Dividend Yield0.5%
Free Cash Flow Margin12.9%

Margins

Gross margin
32.5%
Operating margin
13.4%
Net margin
10.5%

Quarterly Trend

QuarterRevenueYoY growthOperating marginOperating income
Q1 2026 $658M +1.6% 12.9% $85M
Q4 2025 $639M +-0.1% 15.7% $101M
Q3 2025 $625M +3.1% 12.0% $75M
Q2 2025 $619M +3.8% 11.0% $68M
Q1 2025 $647M 14.6% $95M
Q4 2024 $640M 17.8% $114M
Q3 2024 $606M 15.2% $92M
Q2 2024 $596M 14.8% $88M

More on Chemed Corp

Financial data last updated 2026-06-16. Figures compiled from public company filings.

See how VectorShift works for your firm

Request Demo